Comirnaty is the first brand-name COVID-19 vaccine
Pfizer-BioNTech has named its COVID-19 vaccine "Comirnaty" after the FDA fully approved the drug August 23.
Pfizer-BioNTech has named its COVID-19 vaccine "Comirnaty" after the FDA fully approved the drug August 23.